Literature DB >> 9815123

Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function.

G Blanco1, R W Mercer.   

Abstract

The Na-K-ATPase is characterized by a complex molecular heterogeneity that results from the expression and differential association of multiple isoforms of both its alpha- and beta-subunits. At present, as many as four different alpha-polypeptides (alpha1, alpha2, alpha3, and alpha4) and three distinct beta-isoforms (beta1, beta2, and beta3) have been identified in mammalian cells. The stringent constraints on the structure of the Na pump isozymes during evolution and their tissue-specific and developmental pattern of expression suggests that the different Na-K-ATPases have evolved distinct properties to respond to cellular requirements. This review focuses on the functional properties, regulation, and possible physiological relevance of the Na pump isozymes. The coexistence of multiple alpha- and beta-isoforms in most cells has hindered the understanding of the roles of the individual polypeptides. The use of heterologous expression systems has helped circumvent this problem. The kinetic characteristics of different Na-K-ATPase isozymes to the activating cations (Na+ and K+), the substrate ATP, and the inhibitors Ca2+ and ouabain demonstrate that each isoform has distinct properties. In addition, intracellular messengers differentially regulate the activity of the individual Na-K-ATPase isozymes. Thus the regulation of specific Na pump isozymes gives cells the ability to precisely coordinate Na-K-ATPase activity to their physiological requirements.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9815123     DOI: 10.1152/ajprenal.1998.275.5.F633

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  364 in total

1.  Brain plasma membrane Na+,K+-ATPase is inhibited by acetylated tubulin.

Authors:  C H Casale; A D Alonso; H S Barra
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

2.  Heterologous expression of the Na(+),K(+)-ATPase gamma subunit in Xenopus oocytes induces an endogenous, voltage-gated large diameter pore.

Authors:  Q Sha; K L Lansbery; D Distefano; R W Mercer; C G Nichols
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

3.  Protein kinase C phosphorylation of purified Na,K-ATPase: C-terminal phosphorylation sites at the alpha- and gamma-subunits close to the inner face of the plasma membrane.

Authors:  Yasser A Mahmmoud; Flemming Cornelius
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

Review 4.  Endogenous digitalis-like Na+, K+-ATPase inhibitors, and brain function.

Authors:  D Lichtstein; H Rosen
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 5.  The functional role of beta subunits in oligomeric P-type ATPases.

Authors:  K Geering
Journal:  J Bioenerg Biomembr       Date:  2001-10       Impact factor: 2.945

6.  Partitioning of tissue expression accompanies multiple duplications of the Na+/K+ ATPase alpha subunit gene.

Authors:  F C Serluca; A Sidow; J D Mably; M C Fishman
Journal:  Genome Res       Date:  2001-10       Impact factor: 9.043

7.  Mechanisms of the non-neurotransmitter actions of acetylcholine in the neuromuscular apparatus.

Authors:  I I Krivoi
Journal:  Neurosci Behav Physiol       Date:  2002 Mar-Apr

8.  Cellular and subcellular specification of Na,K-ATPase alpha and beta isoforms in the postnatal development of mouse retina.

Authors:  R K Wetzel; E Arystarkhova; K J Sweadner
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

9.  Na pump isoforms in human erythroid progenitor cells and mature erythrocytes.

Authors:  Joseph F Hoffman; Amittha Wickrema; Olga Potapova; Mark Milanick; Douglas R Yingst
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-18       Impact factor: 11.205

Review 10.  Regulation of renal function and structure by the signaling Na/K-ATPase.

Authors:  Jeffrey X Xie; Xin Li; Zijian Xie
Journal:  IUBMB Life       Date:  2013-12-10       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.